CarboDB Glycosphingolipid antigen 1535

From DrugPedia: A Wikipedia for Drug discovery

Revision as of 00:00, 15 January 2001 by Special:Contributions/ (Talk)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search


Contents

Carbohydrate Name

Glycosphingolipid antigen

Carbohydrate Class

Miscellaneous

Source Microbe

Leishmania amazonensis

Basic Structure

The structure of the glycosphingolipid is as follows : &alpha-Neup5Ac-(2-->3)-β-D-Galp-(1-->3)-β-D-GalpNAc-(1-->4)-β-D-Galp [branched to α-Neup5Ac-(2-->3)-] -(1-->4)-β-D-Glcp-(1-?)-CER-(?--/Ceramide/


Proposed functions

N/A

Antigenic Nature used to produce antibodies

L. amazonensis amastigotes

Carrier Name

nil

Conjugation Method

nil

Antibodies

Mab 1C3

Antibody type and class

N/A

Assay System

Indirect immunofluorescence, immunoblotting and immunoprecipitation

Cross-reactivity

This Mab reacted with amastigotes and cross-reacts with gp63 from L. amazonensis promastigotes

Proposed epitopes

ceramide-N-acetylneuraminic acid (GM1) and ceramide-N-tetrose-di-acetylneuraminic acid (GDla) residues seemed to be a part of the epitope

Proposed Utility

MAb 1C3 Fab fragments inhibited about 60% of the penetration of amastigotes into macrophages

Weblink

PubMed Central

External Links